Inhibition of Protein Kinase C by Tamoxifen

Cancer Research

Volumn 45, Issue 6, 1985, Pages 2462-2465

  O'Brian, Catherine A ^a   Liskamp, Rob M ^a   Solomon, David H ^a   Weinstein, I Bernard ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPID; PROTAMINE SULFATE; PROTEIN KINASE C; RADIOISOTOPE; TAMOXIFEN; TELEOCIDIN;

ADENOSINE TRIPHOSPHATE P 32; ANIMAL CELL; CENTRAL NERVOUS SYSTEM; DOSE RESPONSE; DRUG ANTAGONISM; DRUG COMPARISON; DRUG CYTOTOXICITY; DRUG INTERACTION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG RESPONSE; ENZYME INHIBITION; IN VITRO STUDY; INTOXICATION; MOUSE; NONHUMAN; PHARMACOKINETICS; PHORBOL DIBUTYRATE H 3; PRIORITY JOURNAL; RAT;

ANIMAL; BRAIN; PHORBOL 12,13-DIBUTYRATE; PHORBOL ESTERS; PHOSPHOLIPIDS; PROTEIN KINASE C; PROTEIN KINASES; RATS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TAMOXIFEN; TETRADECANOYLPHORBOL ACETATE;

EID: 0021889555     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Adam, H. K., Douglas, E. J., and Kemp, J. O. The metabolism of tamoxifen in humans. Biochem. Pharmacol., 28:145-147, 1979.
2. Coezy, E., Borgna, J. L., and Rochefort, H. Tamoxifen and metabolites in MCF-7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res., 42:317-323, 1982.
3. Daniel, P., Gaskell, S. J., Bishop, H., Campbell, C., and Nicholson, R. I. Determination of tamoxifen and biologically active metabolites in human breast tumors and plasma. Eur. J. Cancer. Clin. Oncol., 17:1183-1189, 1981.
4. Daniel, P., Gaskell, S. J., Bishop, H., and Nicholson, R. I. Determination of tamoxifen and an hydroxylated metabolite in plasma from patients with advanced breast cancer using gas chromatography-mass spectrometry. J. Endocrinol., 83: 401-408, 1978.
5. Darbre, P. D., Curtis, S., and King, R. J. B. Effects of estradiol and tamoxifen on human breast cancer cells in serum-free culture. Cancer Res., 44: 2790-2793, 1984.
6. Fujiki, H., Tanaka, Y., Miyake, R., Kikkawa, U., Nishizuka, Y., and Sugimura, T. Activation of calcium activated, phospholipid dependent protein kinase (protein kinase C) by new classes of tumor promoters: teleocidin and debro-moaplysiatoxin. Biochem. Biophys. Res. Commun., 120:339-343, 1984.
7. Kiang, D. T., and Kennedy, B. J. Tamoxifen (antiestrogen) therapy in advanced breast cancer. Ann. Intern. Med., 87:687-690, 1977.
8. Kikkawa, U., Takai, Y., Tanaka, Y., Miyake, R., and Nishizuka, Y. Protein kinase C as a possible receptor protein of tumor promoting phorbol esters. J. Biol. Chem., 258:11442-11444, 1983.
9. Lam, H. Y. P. Tamoxifen is a calmodulin antagonist in the activation of a cAMP phosphodiesterase. Biochem. Biophys. Res. Commun., 118:27-32, 1984.
10. Legha, S. S., Davis, H. L., and Muggia, F. M. Hormonal therapy of breast cancer: new approaches and concepts. Ann. Intern. Med., 88:69-77, 1978.
11. Le Peuch, C. J., Ballester, R., and Rosen, O. M. Purified rat brain calcium and phosphdipid-dependent protein kinase phosphorylates ribosomal protein S6. Proc. Natl. Acad. Sci. USA, 80:6858-6862, 1983.
12. Lippman, M. E., Bolan, G., and Huff, K. K. The effects of estrogens and antiestrogens on hormone responsive human breast cancer in long term tissue culture. Cancer Res., 36:4595-4601, 1976.
13. Miyake, R., Tanaka, Y., Tsuda, T., Kaibuchi, K., Kikkawa, U., and Nishizuka, Y. Activation of protein kinase C by non-phorbol tumor promoter, mezerein. Biochem. Biophys. Res. Commun., 121:649-656, 1984.
14. Mori, T., Takai, Y., Minakuchi, R., Yu, B., and Nishizuka, Y. Inhibitory action of chtorpromazine, dibucaine, and other phospholipid-interacting drugs on calcium-activated, phospholipid-dependent protein kinase. J. Bid. Chem., 255: 8378-8380, 1980.
15. Mouridsen, H., Palshof, T., Patterson, J., and Battersby, L. Tamoxifen in advanced breast cancer. Cancer Treat. Rev., 5:131-141, 1978.
16. O'Brian, C. A., Lawrence, D. S., Kaiser, E. T., and Weinstein, I. B. Protein kinase C phosphorylates the synthetic peptide Arg-Arg-Lys-Ala-Ser-Gly-Pro-Pro-Val in the presence of phospholipid plus either Ca2* or a phorbol ester tumor promoter. Biochem. Biophys. Res. Commun., 124:296-302, 1984.
17. Phillips, H. J. Dye exclusion tests for cell viability. In: P. F. Kruse and M. K. Patterson (eds.), Tissue Culture Methods and Applications, pp. 406-408. New York: Academic Press, Inc., 1973.
18. Reddel, R. R., Murphy, L. C., and Sutherland, R. L. Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro. Cancer Res., 43:4618-4624, 1983.
19. Sudo, K., Monsma, F. J., and Katzenellenbogen, B. S. Antiestrogen binding sites distinct from the estrogen receptor: subcellular localization ligand specificity and distribution in tissues of the rat. Endocrinology, 112:425-434, 1983.
20. Sutherland, R. L., Green, M. D., Hall, R. E., Reddel, R. R., and Taylor, I. W. Tamoxifen induces accumulation of MCF-7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle. Eur. J. Cancer Clin. Oncol., 19:615-621, 1983.
21. Sutherland, R. L., Hall, R. E., and Taylor, I. W. Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau phase cells. Cancer Res., 43: 3998-4006, 1983.
22. Sutherland, R. L., and Murphy, L. C. Mechanisms of oestrogen antagonism by nonsteroidal antiestrogens. Mol. Cell. Endocrinol., 25:5-23, 1982.
23. Takai, Y., Kishimoto, A., Iwasa, Y., Kawahara, Y., Mori, T., and Nishizuka, Y. Calcium dependent activation of a multifunctional protein kinase by membrane phospholipid. J. Bid. Chem., 254:3692-3695, 1979.
24. Tran, P. L., Castagna, M., Sala, M., Vassent, G., Horowitz, A. D., Schacter, D., and Weinstein, I. B. Differential effects of tumor promoters on phorbolester receptor binding and membrane fluorescence anisotropy in C3H 10TV2 cells. Eur. J. Biochem., 130:155-160, 1983.
25. Watts, C. K. W., Murphy, L. C., and Sutherland, R. L. Microsomal binding sites for nonsteroidal antiestrogens in MCF-7 human mammary cardnoma cells. J. Bid. Chem., 259: 4223-4229, 1984.
26. Weinstein, I. B., Arcdeo, J., Backer, J., Jeffrey, A. M., Hsiao, W., Gattoni-Celli, S., and Kirschmeier, P. Molecular Mechanisms of tumor promotion and multistage cardnogenesis. In: H. Fujiki (ed.), Cellular Interactions by Environmental Tumor Promoters. Tokyo: Japan Scientific Societies Press, pp. 59-74, 1984.